Hepatosplenic T-Cell Lymphoma Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Alpha-beta and gamma delta types

IndicationStatusPhase
DBCOND0040132 (Hepatosplenic T-Cell Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00072514Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesTreatment